-transparent.png){kind=logo}
Sarcoid granulomas metabolized 25-hydroxyvitamin D3 to two unidentified metabolites during in vitro incubation. A two-step high pressure liquid chromatography system revealed two unique elution positions of these sarcoid-derived metabolites that exactly comigrated with the elution positions of 5(Z)-19-nor-10-oxo-25(OH)D3 and 5(E)-19-nor-10-oxo-25(OH)D3, respectively. These unique metabolites did not bind specifically to a protein receptor for 1,25(OH)2D3.
Related Publications
T Okabe, and
S Ishizuka, and
M Fujisawa, and
J Watanabe, and
F Takaku
December 1982,
Biochemical and biophysical research communications,
T Okabe, and
S Ishizuka, and
M Fujisawa, and
J Watanabe, and
F Takaku
February 1984,
Proceedings of the National Academy of Sciences of the United States of America,
T Okabe, and
S Ishizuka, and
M Fujisawa, and
J Watanabe, and
F Takaku
January 1991,
Japanese journal of medicine,
T Okabe, and
S Ishizuka, and
M Fujisawa, and
J Watanabe, and
F Takaku
May 1991,
FEBS letters,
T Okabe, and
S Ishizuka, and
M Fujisawa, and
J Watanabe, and
F Takaku
August 1981,
The Journal of biological chemistry,
T Okabe, and
S Ishizuka, and
M Fujisawa, and
J Watanabe, and
F Takaku
October 1995,
Endocrinology,
T Okabe, and
S Ishizuka, and
M Fujisawa, and
J Watanabe, and
F Takaku
June 1987,
FEBS letters,
T Okabe, and
S Ishizuka, and
M Fujisawa, and
J Watanabe, and
F Takaku
February 1982,
FEBS letters,
T Okabe, and
S Ishizuka, and
M Fujisawa, and
J Watanabe, and
F Takaku
May 1977,
Calcified tissue research,
T Okabe, and
S Ishizuka, and
M Fujisawa, and
J Watanabe, and
F Takaku
April 2024,
Cancers,
